Autogenomics Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
109
- Latest Deal Type
-
M&A
Autogenomics General Information
Description
Developer of an automated molecular testing technology intended to simplify the complex test processes inherent in genetic analysis. The company's automated molecular testing technology offers high-performance genetic marker detection with varying options in automation and throughput, allowing labs to analyze multiple genetic markers at once in a more efficient and automated way.
Contact Information
Website
www.autogenomics.com(Operating Subsidiary)
Corporate Office
- 1600 Faraday Avenue
- Carlsbad, CA 92008
- United States
Corporate Office
- 1600 Faraday Avenue
- Carlsbad, CA 92008
- United States
Autogenomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 23-Apr-2019 | Completed | Generating Revenue | |||
| 8. IPO | 24-Jul-2015 | Cancelled | Generating Revenue | |||
| 7. Later Stage VC | 11-Jan-2013 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series E) | Completed | |||||
| 5. Later Stage VC (Series D) | 07-Jul-2010 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 08-Jun-2010 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 29-Mar-2007 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 20-Jul-2005 | $12.3M | $17.3M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 20-Jun-2003 | $4.99M | $4.99M | Completed | Generating Revenue |
Autogenomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series NC | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 4,515,858 | $0.010000 | $0.17 | $2.75 | $2.75 | 1x | $7.55 | 12.66% |
| Series A | 1,589,600 | $0.010000 | $0.19 | $3.16 | $3.16 | 1x | $4.79 | 8.11% |
Autogenomics Comparisons
Industry
Financing
Details
Autogenomics Competitors (33)
One of Autogenomics’s 33 competitors is Superfluid DX, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Superfluid DX | Venture Capital-Backed | South San Francisco, CA | ||||
| Progentec | Venture Capital-Backed | Oklahoma City, OK | ||||
| Complete Genomics | Formerly VC-backed | San Jose, CA | ||||
| Advanced Cell Diagnostics | Formerly VC-backed | Minneapolis, MN | ||||
| Cepheid | Formerly VC-backed | Sunnyvale, CA |
Autogenomics Patents
Autogenomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025255177-A1 | Glucagon-like peptide-1 receptor related biomarkers and uses thereof | Pending | 03-Jun-2024 | ||
| EP-4022066-A1 | Methods and systems for evaluation of risk of substance use disorders | Pending | 27-Aug-2019 | ||
| EP-4022066-A4 | Methods and systems for evaluation of risk of substance use disorders | Pending | 27-Aug-2019 | ||
| US-10998105-B2 | Methods and systems for evaluation of risk of substance use disorders | Active | 27-Aug-2019 | ||
| US-20210065909-A1 | Methods and systems for evaluation of risk of substance use disorders | Active | 27-Aug-2019 | G16H20/10 |
Autogenomics Signals
Autogenomics Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bantam Group | Angel Group | Minority | ||
| Catalina Ventures | Venture Capital | Minority | ||
| MemorialCare Innovation Fund | Corporate Venture Capital | Minority | ||
| Angel (individual) | Minority |
Autogenomics FAQs
-
When was Autogenomics founded?
Autogenomics was founded in 1999.
-
Where is Autogenomics headquartered?
Autogenomics is headquartered in Carlsbad, CA.
-
What is the size of Autogenomics?
Autogenomics has 109 total employees.
-
What industry is Autogenomics in?
Autogenomics’s primary industry is Biotechnology.
-
Is Autogenomics a private or public company?
Autogenomics is a Private company.
-
What is Autogenomics’s current revenue?
The current revenue for Autogenomics is .
-
How much funding has Autogenomics raised over time?
Autogenomics has raised $82.9M.
-
Who are Autogenomics’s investors?
Bantam Group, Catalina Ventures, MemorialCare Innovation Fund, and have invested in Autogenomics.
-
Who are Autogenomics’s competitors?
Superfluid DX, Progentec, Complete Genomics, Advanced Cell Diagnostics, and Cepheid are some of the 33 competitors of Autogenomics.
-
When was Autogenomics acquired?
Autogenomics was acquired on 23-Apr-2019.
-
Who acquired Autogenomics?
Autogenomics was acquired by SOLVD Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process